Neurological Complications of Immunotherapy


  • To describe type and pattern of neurotoxicity encountered in patients treated with checkpoint inhibitors and CAR-T cells
  • To define potential biomarkers of immunotherapy associated neurotoxicity
  • To discuss management considerations of patients with immunotherapy
Course summary
Course opens: 
Course expires: 

Jorg Dietrich, MD, PhD

Harvard Medical School



Please login or register to take this course.

Please fill out the webform at the time of enrollment. *See step 2 in the instructions.

Instructions on How to Watch the Module:

  1. Click the Take Course Button
  2. On the course progress bar, click the webform.
  3. Click the blue start button to fill out the webform.
  4. Complete the webform, then click submit.
  5. Then Click next to proceed to the video

If you have any technical difficulties or have any questions, please reach out to